Table 1. Antiferroptotic Effects of MB/MV Analogues (1–5) in FRDA Lymphocytes against RSL3-Induced Lipid Peroxidationa.
| Compound | RSL3 challenge lipid peroxidation inhibition EC50 (nM) |
|---|---|
| MB | 88 ± 13 |
| Acetylated MBb | >2500 |
| MV | 26 ± 3 |
| 1a | 76 ± 6 |
| 1b | 14 ± 1 |
| 2a | 53 ± 3 |
| 2b | 12 ± 1 |
| 3a | 38 ± 3 |
| 3b | 9 ± 1 |
| 4a | 54 ± 5 |
| 4b | 16 ± 1 |
| 5a | 70 ± 5 |
| 5b | 25 ± 3 |
| Lip-1 | 22 ± 2 |
| Fer-1 | 48 ± 2 |
| α-TOH | >500 |